Medpace Holdings Total Assets 2014-2024 | MEDP

Medpace Holdings total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Medpace Holdings total assets for the quarter ending March 31, 2024 were $1.796B, a 28.66% increase year-over-year.
  • Medpace Holdings total assets for 2023 were $1.657B, a 22.5% increase from 2022.
  • Medpace Holdings total assets for 2022 were $1.352B, a 18.52% decline from 2021.
  • Medpace Holdings total assets for 2021 were $1.66B, a 19.36% increase from 2020.
Medpace Holdings Annual Total Assets
(Millions of US $)
2023 $1,657
2022 $1,352
2021 $1,660
2020 $1,391
2019 $1,143
2018 $968
2017 $951
2016 $979
2015 $984
2014 $1,097
2013 $0
Medpace Holdings Quarterly Total Assets
(Millions of US $)
2024-03-31 $1,796
2023-12-31 $1,657
2023-09-30 $1,487
2023-06-30 $1,407
2023-03-31 $1,396
2022-12-31 $1,352
2022-09-30 $1,328
2022-06-30 $1,315
2022-03-31 $1,344
2021-12-31 $1,660
2021-09-30 $1,577
2021-06-30 $1,470
2021-03-31 $1,451
2020-12-31 $1,391
2020-09-30 $1,296
2020-06-30 $1,222
2020-03-31 $1,138
2019-12-31 $1,143
2019-09-30 $1,072
2019-06-30 $1,017
2019-03-31 $1,007
2018-12-31 $968
2018-09-30 $950
2018-06-30 $968
2018-03-31 $973
2017-12-31 $951
2017-09-30 $949
2017-06-30 $964
2017-03-31 $966
2016-12-31 $979
2016-09-30 $976
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2014-12-31 $1,097
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $12.318B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.048B 15.56
Cencora (COR) United States $47.467B 18.94
ICON (ICLR) Ireland $25.527B 24.10
DiDi Global (DIDIY) China $23.901B 0.00
Avantor (AVTR) United States $17.269B 23.79
Viatris (VTRS) United States $13.856B 3.96
CochLear (CHEOY) $13.551B 0.00
Revvity (RVTY) United States $12.684B 22.08
Charles River Laboratories (CRL) United States $12.333B 22.48
EUROFINS SCIENT (ERFSF) Luxembourg $11.750B 0.00
Natera (NTRA) United States $11.049B 0.00
Solventum (SOLV) United States $10.961B 0.00
Amplifon S.p.A (AMFPF) Italy $7.290B 37.01
HealthEquity (HQY) United States $6.795B 50.77
Bausch + Lomb (BLCO) Canada $5.236B 20.14
Organon (OGN) United States $4.783B 4.63
Doximity (DOCS) United States $4.461B 33.21
PACS (PACS) United States $3.596B 0.00
Surgery Partners (SGRY) United States $3.228B 30.00
Sotera Health (SHC) United States $3.190B 15.65
Progyny (PGNY) United States $3.133B 52.58
Life Times (LTH) United States $2.882B 31.85
GoodRx Holdings (GDRX) United States $2.749B 139.20
Premier (PINC) United States $2.531B 9.26
Teladoc Health (TDOC) United States $2.325B 0.00
Agilon Health (AGL) United States $2.191B 0.00
AMN Healthcare Services Inc (AMN) United States $2.167B 7.01
BrightSpring Health Services (BTSG) United States $1.845B 0.00
Agiliti (AGTI) United States $1.374B 22.44
Establishment Labs Holdings (ESTA) $1.344B 0.00
NovoCure (NVCR) Jersey $1.328B 0.00
Alignment Healthcare (ALHC) United States $0.979B 0.00
Pediatrix Medical (MD) United States $0.776B 8.03
Embecta (EMBC) United States $0.627B 4.14
Auna S.A (AUNA) Luxembourg $0.558B 0.00
InnovAge Holding (INNV) United States $0.542B 0.00
Enhabit (EHAB) United States $0.510B 46.23
COMPASS Pathways (CMPS) United Kingdom $0.502B 0.00
LifeMD (LFMD) United States $0.450B 0.00
Sonida Senior Living (SNDA) United States $0.423B 0.00
CareDx (CDNA) United States $0.413B 0.00
Beauty Health (SKIN) United States $0.389B 0.00
MultiPlan (MPLN) United States $0.375B 0.00
DocGo (DCGO) United States $0.367B 58.67
ModivCare (MODV) United States $0.353B 4.68
Sera Prognostics (SERA) United States $0.326B 0.00
GeneDx Holdings (WGS) United States $0.308B 0.00
Sharecare (SHCR) United States $0.277B 0.00
Ascend Wellness Holdings (AAWH) United States $0.265B 0.00
Biodesix (BDSX) United States $0.145B 0.00
So-Young (SY) China $0.121B 40.67
Oncology Institute (TOI) United States $0.089B 0.00
Pono Capital Two (PTWO) United States $0.077B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
Co-Diagnostics (CODX) United States $0.036B 0.00
Nutex Health (NUTX) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.030B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
SeaStar Medical Holding (ICU) United States $0.028B 0.00
DermTech (DMTK) United States $0.021B 0.00
OncoCyte (OCX) United States $0.020B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.014B 0.00
BIMI Holdings (BIMI) United States $0.014B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
OpGen (OPGN) United States $0.007B 0.00
NewGenIvf Group (NIVF) Singapore $0.006B 0.00
Assure Holdings (IONM) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00